{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:46:02Z","timestamp":1789753562099,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R35HL155657"],"award-info":[{"award-number":["R35HL155657"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08 HL159290"],"award-info":[{"award-number":["K08 HL159290"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jtha.2024.03.020","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T12:29:08Z","timestamp":1712060948000},"page":"1984-1996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia"],"prefix":"10.1016","volume":"22","author":[{"given":"Yohei","family":"Hisada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra J.","family":"Archibald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu","family":"Dwarampudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Balas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Hageman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel S.","family":"Key","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Mackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Gangaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.03.020_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/bjh.14631","article-title":"Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia","volume":"177","author":"Ho","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.03.020_bib2","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood.V75.11.2112.2112","article-title":"Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients","volume":"75","author":"Rodeghiero","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib3","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/leu.2017.71","article-title":"Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013","volume":"31","author":"Lehmann","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jtha.2024.03.020_bib4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1182\/blood-2011-04-346437","article-title":"Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid","volume":"118","author":"Park","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3324\/haematol.2011.046490","article-title":"Treatment advances have not improved the early death rate in acute promyelocytic leukemia","volume":"97","author":"McClellan","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.03.020_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009324","article-title":"Analysis of early death in newly diagnosed acute promyelocytic leukemia patients","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jtha.2024.03.020_bib7","doi-asserted-by":"crossref","first-page":"E370","DOI":"10.1002\/ajh.25252","article-title":"Complications and early mortality in patients with acute promyelocytic leukemia treated in California","volume":"93","author":"Ho","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.03.020_bib8","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1538-7836.2005.01467.x","article-title":"The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment","volume":"3","author":"De Stefano","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2004.07.016","article-title":"Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis","volume":"115","author":"Ziegler","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.03.020_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjc.6602945","article-title":"Increased risk of venous thromboembolism in patients with acute leukaemia","volume":"94","author":"Mohren","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtha.2024.03.020_bib11","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1182\/blood-2008-08-175745","article-title":"Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival","volume":"113","author":"Ku","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib12","first-page":"1530","article-title":"The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia","volume":"91","author":"Webert","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.03.020_bib13","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/bloodadvances.2021006166","article-title":"Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy","volume":"6","author":"Versluis","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.03.020_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.thromres.2004.11.001","article-title":"Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients","volume":"116","author":"Dally","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.03.020_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0609.2006.00803.x","article-title":"Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome","volume":"78","author":"Yanada","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtha.2024.03.020_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/10428199309064261","article-title":"Bleeding and thrombosis in acute lymphoblastic leukemia","volume":"11","author":"Barbui","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtha.2024.03.020_bib17","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V82.11.3241.3241","article-title":"Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group","volume":"82","author":"Fenaux","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib18","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1007\/s002800051058","article-title":"All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG)","volume":"40","author":"Asou","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jtha.2024.03.020_bib19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","article-title":"All-trans-retinoic acid in acute promyelocytic leukemia","volume":"337","author":"Tallman","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.03.020_bib20","first-page":"1192","article-title":"A\u00a0randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia","volume":"94","author":"Fenaux","year":"1999","journal-title":"The European APL Group. Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib21","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/leu.2009.183","article-title":"High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG","volume":"23","author":"Lengfelder","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.jtha.2024.03.020_bib22","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1182\/blood-2016-10-747170","article-title":"Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era","volume":"129","author":"Mantha","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.thromres.2014.11.026","article-title":"Thrombotic events in acute promyelocytic leukemia","volume":"135","author":"Mitrovic","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.03.020_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000098700","article-title":"Symptomatic venous thromboembolism and thrombophilic status in adult acute leukemia: a single-center experience of 114 patients at diagnosis","volume":"117","author":"Melillo","year":"2007","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jtha.2024.03.020_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12959-021-00294-7","article-title":"Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia","volume":"19","author":"Zhang","year":"2021","journal-title":"Thromb J"},{"key":"10.1016\/j.jtha.2024.03.020_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.03.020_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40164-015-0018-x","article-title":"Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study","volume":"4","author":"Dicke","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jtha.2024.03.020_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V92.1.143.413k18_143_151","article-title":"Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells","volume":"92","author":"Falanga","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3324\/haematol.2011.055343","article-title":"Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography","volume":"97","author":"Marchetti","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.03.020_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.thromres.2013.11.008","article-title":"Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state","volume":"133","author":"Gheldof","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.03.020_bib31","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/blood.V84.9.3001.3001","article-title":"All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells","volume":"84","author":"Koyama","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib32","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.leu.2401448","article-title":"Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents","volume":"13","author":"Zhu","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.jtha.2024.03.020_bib33","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.V86.3.1072.1072","article-title":"Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid","volume":"86","author":"Falanga","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib34","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood.V86.9.3535.bloodjournal8693535","article-title":"Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia","volume":"86","author":"De Stefano","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib35","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1538-7836.2004.00787.x","article-title":"Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia","volume":"2","author":"Tallman","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib36","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","article-title":"Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles","volume":"68","author":"Gyorgy","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jtha.2024.03.020_bib37","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","article-title":"Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients","volume":"122","author":"Geddings","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00277-008-0446-3","article-title":"Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation","volume":"87","author":"Langer","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2024.03.020_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.thromres.2013.12.029","article-title":"Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia","volume":"133","author":"Thaler","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.03.020_bib40","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00277-021-04533-9","article-title":"Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study","volume":"100","author":"Zhao","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2024.03.020_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/jth.12838","article-title":"Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH","volume":"13","author":"Thachil","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/10245332.2018.1470069","article-title":"Characteristics of fibrinolytic disorders in acute promyelocytic leukemia","volume":"23","author":"Wang","year":"2018","journal-title":"Hematology"},{"key":"10.1016\/j.jtha.2024.03.020_bib43","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1182\/blood.V77.9.1949.1949","article-title":"The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia","volume":"77","author":"Sakata","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtha.2024.03.020_bib45","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1515\/CCLM.2010.311","article-title":"Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia","volume":"48","author":"Gao","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2024.03.020_bib46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1160\/TH17-08-0596","article-title":"Contact system activation and cancer: new insights in the pathophysiology of cancer-associated thrombosis","volume":"118","author":"Campello","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib47","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jtha.2024.03.020_bib48","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.03.020_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice","volume":"10","author":"Brill","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib50","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/ATVBAHA.111.242859","article-title":"Neutrophil extracellular trap (NET) impact on deep vein thrombosis","volume":"32","author":"Fuchs","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.03.020_bib51","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2018-10-862243","article-title":"Neutrophils: back in the thrombosis spotlight","volume":"133","author":"Noubouossie","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib52","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/ijms22020821","article-title":"Dynamic changes in the ability to release neutrophil extraCellular traps in the course of childhood acute leukemias","volume":"22","author":"Ostafin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.03.020_bib53","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1097\/MPH.0000000000001015","article-title":"Reduced neutrophil elastase activity and neutrophil extracellular traps in pediatric acute myeloid leukemia may increase the rate of infections","volume":"40","author":"Berger-Achituv","year":"2018","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtha.2024.03.020_bib54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbamcr.2012.12.012","article-title":"Granulocyte maturation determines ability to release chromatin NETs and loss of DNA damage response; these properties are absent in immature AML granulocytes","volume":"1833","author":"Lukasova","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jtha.2024.03.020_bib55","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MPH.0000000000001280","article-title":"Risk markers for significant bleeding and thrombosis in pediatric acute promyelocytic leukemia; report from the Children's Oncology Group Study AAML0631","volume":"41","author":"Rajpurkar","year":"2019","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtha.2024.03.020_bib57","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib58","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/jth.12028","article-title":"Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis","volume":"10","author":"Carrier","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/rth2.12165","article-title":"Measurement of tissue factor activity in extracellular vesicles from human plasma samples","volume":"3","author":"Hisada","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib60","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1111\/jth.15003","article-title":"Quantification of citrullinated histones: development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma","volume":"18","author":"Thalin","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib61","article-title":"Evaluation of commercial ELISAs to measure tissue factor in human plasma","volume":"7","author":"Sachetto","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.020_bib62","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jtha.2024.03.020_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"R\u00a0Stat Soc S B Stat"},{"key":"10.1016\/j.jtha.2024.03.020_bib64","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJM199904013401303","article-title":"Annexin II and bleeding in acute promyelocytic leukemia","volume":"340","author":"Menell","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.03.020_bib65","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1182\/blood-2010-07-298851","article-title":"Regulation of S100A10 by the PML-RAR-alpha oncoprotein","volume":"117","author":"O'Connell","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.020_bib66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2024.03.020_bib67","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2016-02-701094","article-title":"Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia","volume":"128","author":"Libourel","year":"2016","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624001788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624001788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:09:48Z","timestamp":1762549788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624001788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1538783624001788"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.03.020","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.18.23297216","asserted-by":"object"}]},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}